CVS Health Sees Unusually Large Options Volume (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) saw unusually large options trading activity on Tuesday. Stock investors bought 30,223 call options on the company. This represents an increase of approximately 52% compared to the typical daily volume of 19,874 call options.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS is expanding its retail footprint in 2026 — management plans roughly 60 store openings this year (including nearly 20 smaller pharmacy‑only or “apothecary” sites) as it pivots from prior net closures; the company opened its first pharmacy‑only location in Chicago. CVS Pharmacy® celebrates opening of first pharmacy-only location in Chicago
• Positive Sentiment: Market reaction to the store strategy: coverage highlights (Bloomberg/WSJ) that CVS will open more stores than it closes in 2026 — signals management sees profitable opportunities in community pharmacy. CVS to Grow Store Footprint This Year With 60 New Locations
• Positive Sentiment: Unusually heavy call‑option activity: traders purchased ~30,223 calls (about +52% vs. average), indicating speculative bullish positioning that can amplify intraday upside.
• Neutral Sentiment: Piper Sandler trimmed its price target from $101 to $99 but kept an Overweight rating — a modest PT cut that still implies sizable upside vs. the current level, so the note is supportive but slightly cautious. Benzinga
• Neutral Sentiment: Analyst/education pieces (Zacks/Yahoo) are flagging CVS as a company to watch with earnings‑beat potential using tools like Earnings ESP — these stories can attract short‑term interest but are speculative ahead of actual results. CVS Health (CVS) Increases Yet Falls Behind Market: What Investors Need to Know
• Negative Sentiment: Regulatory/legal risk: CVS reached a proposed FTC settlement over insulin pricing — the final terms and any financial penalties or behavioral remedies remain a potential headwind. CVS Health (CVS) Reaches Proposed FTC Settlement on Insulin Pricing

CVS Health Stock Performance

CVS Health stock opened at $71.86 on Wednesday. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The firm has a market cap of $91.42 billion, a P/E ratio of 52.07, a P/E/G ratio of 0.73 and a beta of 0.49. CVS Health has a 1-year low of $58.35 and a 1-year high of $85.15. The firm has a 50-day moving average of $76.29 and a 200-day moving average of $77.74.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The company had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.CVS Health’s revenue was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts expect that CVS Health will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Investors of record on Thursday, April 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date is Thursday, April 23rd. CVS Health’s dividend payout ratio is currently 192.75%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in CVS. Norges Bank purchased a new stake in shares of CVS Health in the 4th quarter worth about $1,666,265,000. Wellington Management Group LLP increased its position in shares of CVS Health by 193.2% during the fourth quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock valued at $1,473,270,000 after buying an additional 12,233,675 shares during the period. Amundi raised its stake in CVS Health by 95.3% in the third quarter. Amundi now owns 7,453,980 shares of the pharmacy operator’s stock worth $572,665,000 after buying an additional 3,637,943 shares in the last quarter. Invesco Ltd. lifted its holdings in CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after buying an additional 3,118,626 shares during the period. Finally, Capital Research Global Investors boosted its position in CVS Health by 24.5% during the 3rd quarter. Capital Research Global Investors now owns 11,469,250 shares of the pharmacy operator’s stock valued at $864,667,000 after acquiring an additional 2,253,531 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have issued reports on CVS shares. Wolfe Research cut their price target on shares of CVS Health from $100.00 to $97.00 and set an “outperform” rating for the company in a research report on Monday, March 2nd. Morgan Stanley boosted their target price on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Bank of America dropped their target price on CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a report on Tuesday, January 27th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Finally, TD Cowen reiterated a “buy” rating on shares of CVS Health in a research report on Friday, March 13th. Twenty analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.95.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.